HomeBUSINESS
BUSINESS

Takeda Joins Liver-Focused Biotech Launch with US$100 Million Partnership
(Aug.10.2018)

Takeda Pharmaceutical has struck a strategic partnership with Ambys Medicines, a newborn US biotech specializing in liver diseases, in a bid to help drive the Redwood City, California company’s research across various modalities of treatments, to which it gained an option outside the US ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 20.

News Calendar